Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
2UgJmemWVWX00zzv
Listen
